ALNY Alnylam Pharmaceuticals, Inc.
Stock Price & Overview

$324.691.88 (+0.58%)4:00 PM 07/17/25
NASDAQ | $USD | Post-Market: $327.13 +2.44 (+0.75%) 7:19 PM

Valuation Metrics

ALNY Valuation Grade

Type
Grade
ALNY
Sector Median
% Diff. to Sector
ALNY 5Y Avg.
% Diff. to 5Y Avg.
P/E Non-GAAP (TTM)
-Rating: Not Covered
NM
16.46
NM
-
-
P/E Non-GAAP (FWD)
F
231.13
17.30
1,235.81%
-
NM
P/E GAAP (TTM)
NM
26.50
NM
-
-
P/E GAAP (FWD)
NM
23.52
NM
-
-
PEG GAAP (TTM)
-
0.77
-
-
-
PEG Non-GAAP (FWD)
-
1.78
-
-
-
EV / Sales (TTM)
17.96
3.36
433.94%
22.93
-21.66%
EV / Sales (FWD)
14.24
3.20
345.62%
18.89
-24.60%
EV / EBITDA (TTM)
NM
14.02
NM
-
NM
EV / EBITDA (FWD)
556.98
11.99
4,544.32%
-
NM
EV / EBIT (TTM)
NM
19.77
NM
-
NM
EV / EBIT (FWD)
599.66
15.12
3,866.89%
-
NM
Price / Sales (TTM)
17.67
3.44
413.61%
23.72
-25.50%
Price / Sales (FWD)
14.21
3.54
301.78%
19.80
-28.22%
Price / Book (TTM)
364.41
2.42
14,984.71%
181.06
101.27%
Price / Book (FWD)
126.27
2.62
4,715.03%
-
NM
Price / Cash Flow (TTM)
NM
15.35
NM
-
NM
Price / Cash Flow (FWD)
123.35
13.89
788.17%
-
NM
Dividend Yield (TTM)
-
1.71%
-
-
-

Go Premium to see Valuation Grades on ALNY

*Grades are relative to the Health Care sector

**NM signifies a non meaningful value. A dash signifies the data is not available.

ALNY Price/Earnings (P/E) Ratio

View Alnylam Pharmaceuticals, Inc. (ALNY) current and estimated P/E ratio data provided by Seeking Alpha.

Price/Earnings Ratio

Consensus EPS Estimate Growth Rate

Capital Structure